{"id":"W4389229545","doi":"10.1182/blood-2023-180772","title":"Incremental Healthcare Resource Utilization and Costs Associated with Non-Optimal Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Tyrosine Kinase Inhibitors (TKI) in Early Lines of Therapy in the United States (US)","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Discontinuation; Dasatinib; Bosutinib; Nilotinib; Internal medicine; Ponatinib; Cohort; Imatinib mesylate; Drug holiday; Imatinib; Oncology; Pediatrics; Myeloid leukemia; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005944467,0.0003436715,0.000365677,0.0009120726,0.0003306662,0.0009421253,0.0005474383,0.0005072119,0.001953866],"category_scores_gemma":[0.002752811,0.0003162107,0.001160291,0.001589043,0.0002216637,0.0006617255,0.0008554868,0.0009061745,0.0001936429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001426638,"about_ca_system_score_gemma":0.0008326593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01859172,"about_ca_topic_score_gemma":0.01983627,"domain_scores_codex":[0.9991966,0.0001829951,0.0001521212,0.0001802615,0.0001248436,0.000163204],"domain_scores_gemma":[0.9979275,0.0002456202,0.001321258,0.00006849614,0.0001187572,0.0003183412],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002893927,0.0000691807,0.9977263,0.00001568486,0.0001630696,0.00005759485,0.00002074942,0.0004064713,0.00004813832,0.00005712589,0.0003053767,0.000841002],"study_design_scores_gemma":[0.00004500668,0.0002196053,0.9955713,0.0000243184,0.0001129319,0.0003720889,0.0002001626,0.002950016,0.00005348979,0.00009796269,0.000341858,0.00001130363],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953381,0.0002376018,0.00004729827,0.0001083757,0.000007244114,0.0000218633,0.003973475,0.000003118705,0.0002629047],"genre_scores_gemma":[0.9957296,0.0001477882,0.00008589342,0.00005662376,0.0000137336,0.00002593891,0.003836105,0.000001357163,0.0001028706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01859172,"threshold_uncertainty_score":0.03696704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01786702761907384,"score_gpt":0.2703753378904185,"score_spread":0.2525083102713446,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}